AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 31 min read

Vallance Robert R sold $352K of VC

Vallance Robert R (Senior Vice President) sold 3,000 shares of VISTEON CORP (VC) at an average of $117.47 ($116.50–$119.40, $0.35M total) across 2 trades over 2026-06-01 to 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Vallance Robert R
Published Jun 3, 2026, 12:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$VC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed sale reduces insider ownership and may be interpreted as a lack of confidence, prompting short‑term price weakness.

02

Market read

Primary insider sale filing; modest size but first disclosure, relevant for short‑term traders monitoring insider activity.

03

What to watch

Potential upcoming earnings or strategic announcements that may offset the sell pressure.

Relevance 3/10Novelty 3/10Timing: today

Background

Form 4 filings disclose insider transactions; a senior VP's sale is publicly reported via SEC EDGAR.

Market effects

Sector

Minimal impact on the automotive supplier sector; the sale is company‑specific.

Regional

No notable regional effect.

Global

Limited to Visteon investors and analysts.

Counterpoint

What could challenge this read

The sale could be routine under a 10b5-1 plan and not reflect negative sentiment.

Key entities

  • Company
    Visteon Corp

    Automotive supplier listed on NYSE under ticker VST.

  • Insider
    Robert R. Vallance

    Senior Vice President of Visteon, reporting a sale of 3,000 shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

VC insider trading history →

Related articles

OCT 22
Med

Visteon Corporation Q3 2026 Earnings Call Summary

Visteon Corporation reported Q3 2026 earnings, highlighting 10 percentage points of market outperformance despite a 5% decline in vehicle production. The company addressed $77 million in warranty charges and managed inflation in PCBs. For 2027, Visteon anticipates $500 million in incremental costs and aims to maintain EBITDA targets through customer recoveries. China sales are expected to grow in Q4 2026, driven by high-performance compute launches.

finance.yahoo.com3 min
OCT 22
Med

Visteon (VC) Q3 2026 Earnings Call Transcript

Visteon (VC) reported Q3 2026 earnings, highlighting a $200M share repurchase and sales growth despite market challenges. Sales grew in Americas, Europe, and Asia (excluding China), with China sales expected to recover in Q4. The company launched 21 new products, including high-value cockpit technologies, and secured $1B in new business bookings, targeting $6B for the year. Strategic wins include programs with Toyota, Maruti Suzuki, and Tata Motors.

finance.yahoo.com3 min
OCT 22
$VCMedAI 8/10

What Visteon (VC) Said on Its Q3 Earnings Call

Visteon (VC) reported Q3 earnings, noting regional sales trends and product launches. Sales rose 14% in Asia excluding China, but faced challenges in the Americas and China. The company expects China sales to grow in Q4 with new launches. Visteon launched 21 products and booked $1B in new business, maintaining its $6B annual target. It updated guidance, raising full-year sales to $3.8B-$3.85B but lowering adjusted EBITDA to $370M-$410M. Q4 sales are expected to be $940M, flat YoY.

finance.yahoo.com2 min